Oxford Biomedica Dividend

Dividend criteria checks 0/6

Oxford Biomedica no tiene antecedentes de pago de dividendos.

Key information

n/a

Dividend yield

n/a

Payout ratio

Industry average yield1.7%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Earnings per share-UK£0.62
Dividend yield forecast in 3Y0%

Recent dividend updates

No updates

Recent updates

Is Oxford Biomedica (LON:OXB) Using Debt Sensibly?

Oct 19
Is Oxford Biomedica (LON:OXB) Using Debt Sensibly?

Oxford Biomedica plc (LON:OXB) Not Doing Enough For Some Investors As Its Shares Slump 28%

Aug 23
Oxford Biomedica plc (LON:OXB) Not Doing Enough For Some Investors As Its Shares Slump 28%

Is Oxford Biomedica plc (LON:OXB) Expensive For A Reason? A Look At Its Intrinsic Value

Feb 15
Is Oxford Biomedica plc (LON:OXB) Expensive For A Reason? A Look At Its Intrinsic Value

Is Oxford Biomedica (LON:OXB) Using Too Much Debt?

Oct 06
Is Oxford Biomedica (LON:OXB) Using Too Much Debt?

Investors Shouldn't Be Too Comfortable With Oxford Biomedica's (LON:OXB) Robust Earnings

May 02
Investors Shouldn't Be Too Comfortable With Oxford Biomedica's (LON:OXB) Robust Earnings

We're Not Worried About Oxford Biomedica's (LON:OXB) Cash Burn

Jun 29
We're Not Worried About Oxford Biomedica's (LON:OXB) Cash Burn

We Think Oxford Biomedica (LON:OXB) Can Easily Afford To Drive Business Growth

Mar 09
We Think Oxford Biomedica (LON:OXB) Can Easily Afford To Drive Business Growth

What Kind Of Shareholders Own Oxford Biomedica plc (LON:OXB)?

Feb 08
What Kind Of Shareholders Own Oxford Biomedica plc (LON:OXB)?

Investors Who Bought Oxford Biomedica (LON:OXB) Shares Five Years Ago Are Now Up 202%

Dec 24
Investors Who Bought Oxford Biomedica (LON:OXB) Shares Five Years Ago Are Now Up 202%

The Independent Non-Executive Director of Oxford Biomedica plc (LON:OXB), Andrew John Heath, Just Sold 79% Of Their Holding

Dec 02
The Independent Non-Executive Director of Oxford Biomedica plc (LON:OXB), Andrew John Heath, Just Sold 79% Of Their Holding

Oxford Biomedica (LON:OXB) Is In A Good Position To Deliver On Growth Plans

Dec 01
Oxford Biomedica (LON:OXB) Is In A Good Position To Deliver On Growth Plans

Stability and Growth of Payments

Fetching dividends data

Dividendo estable: No hay datos suficientes para determinar si los dividendos por acción de OXB han sido estables en el pasado.

Dividendo creciente: Datos insuficientes para determinar si los pagos de dividendos de OXB han aumentado.


Dividend Yield vs Market

Oxford Biomedica Dividend Yield vs Market
How does OXB dividend yield compare to the market?
SegmentDividend Yield
Company (OXB)n/a
Market Bottom 25% (GB)2.2%
Market Top 25% (GB)5.9%
Industry Average (Biotechs)1.7%
Analyst forecast in 3 Years (OXB)0%

Dividendo destacado: No es posible evaluar la rentabilidad por dividendo de OXB en comparación con el 25% inferior de los pagadores de dividendos, ya que la empresa no ha comunicado ningún pago reciente.

Alto dividendo: No es posible evaluar la rentabilidad por dividendo de OXB en comparación con el 25% de los principales pagadores de dividendos, ya que la empresa no ha comunicado ningún pago reciente.


Earnings Payout to Shareholders

Cobertura de los beneficios: No hay datos suficientes para calcular el ratio de reparto de OXB para determinar si sus dividendos están cubiertos por los beneficios.


Cash Payout to Shareholders

Cobertura de flujo de caja: No es posible calcular la sostenibilidad de los dividendos, ya que OXB no ha comunicado ningún pago.


Discover strong dividend paying companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.